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CARMIL2 is a novel molecular connection 
between vimentin and actin essential for cell 
migration and invadopodia formation
ABSTRACT Cancer cell migration requires the regulation of actin networks at protrusions 
associated with invadopodia and other leading edges. Carcinomas become invasive after 
undergoing an epithelial–mesenchymal transition characterized by the appearance of vimen-
tin filaments. While vimentin expression correlates with cell migration, the molecular connec-
tions between vimentin- and actin-based membrane protrusions are not understood. We re-
port here that CARMIL2 (capping protein, Arp2/3, myosin-I linker 2) provides such a molecular 
link. CARMIL2 localizes to vimentin, regulates actin capping protein (CP), and binds to mem-
branes. CARMIL2 is necessary for invadopodia formation, as well as cell polarity, lamellipo-
dial assembly, membrane ruffling, macropinocytosis, and collective cell migration. Using 
point mutants and chimeras with defined biochemical and cellular properties, we discovered 
that localization to vimentin and CP binding are both essential for the function of CARMIL2 
in cells. On the basis of these results, we propose a model in which dynamic vimentin fila-
ments target CARMIL2 to critical membrane-associated locations, where CARMIL2 regulates 
CP, and thus actin assembly, to create cell protrusions.
INTRODUCTION
Invasion of body tissues by metastatic tumor cells is the main cause 
of death in patients with cancer (Weigelt et al., 2005). Cell migration 
and invasion require assembly of actin-based structures, such as in-
vadopodia. Within invadopodia and at the leading edge of migrat-
ing cells in general, actin filaments polymerize at their barbed ends, 
which are oriented toward the plasma membrane. The addition of 
actin subunits onto barbed ends provides the force that generates 
protrusion of the plasma membrane. Regulation of the number of 
free barbed ends is crucial for controlling actin networks during cell 
migration and invasion (Pollard and Cooper, 2009).
Invadopodia and protrusions at the leading edges of migrating 
cells are based on assemblies of branching networks of short actin 
filaments interspersed with bundles of longer unbranched fila-
ments (Cooper and Sept, 2008; Nurnberg et al., 2011). A key regu-
lator of actin filament barbed ends is capping protein (CP). For 
branched networks that are induced to form by the Arp2/3 com-
plex, CP contributes to network assembly and architecture by cap-
ping older filaments, which restricts filament length and confines 
polymerization to new filaments near the membrane (Cooper and 
Sept, 2008; Pollard and Cooper, 2009; Pollard and Borisy, 2003; 
Nurnberg et al., 2011). Loss of CP in cells leads to loss of Arp2/3-
based lamella and lamellipodia, increased numbers of filopodia, 
and decreased cell migration (Mejillano et al., 2004). Therefore 
insight into the regulation of CP is critical for understanding actin-
based motility.
CARMIL (CP, Arp2/3, myosin-I linker) family proteins are large 
(∼1400 aa) multidomain polypeptides that directly bind and regu-
late CP (Edwards et al., 2014). CARMILs contain a CP-binding re-
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CP-interaction (CPI) motif and the CARMIL-specific interaction 
(CSI) motif (Hernandez-Valladares et al., 2010). CARMIL proteins 
have similar domain architectures (Figure 1A), consisting of an N-
terminal noncanonical pleckstrin homology (PH) domain, a leucine-
rich repeat (LRR) domain, a helical homodimerization domain (HD), 
and an extended intrinsically disordered region that contains the 
CBR and a proline-rich domain (PRD), which interacts with SH3 do-
mains of class-I myosins (Zwolak et al., 2013; Edwards et al., 2014).
Vertebrates have three genes encoding highly conserved CAR-
MIL isoforms that have distinct cellular functions (Liang et al., 
2009; Edwards et al., 2014). CARMIL1 regulates CP at the leading 
edges of migrating cells, playing critical roles in lamellipodia for-
mation, ruffling, and macropinocytosis (Edwards et al., 2013). For 
CARMIL2 and CARMIL3, much less is known. CARMIL2 was identi-
fied as a transcript down-regulated in the affected skin of psoriasis 
patients (Matsuzaka et al., 2004). Widely expressed in human tis-
sues (Matsuzaka et al., 2004), CARMIL2 has been implicated in 
costimulation pathways leading to T-cell activation (Liang et al., 
2013). Cultured HT1080 fibrosarcoma cells lacking CARMIL2 show 
impaired migration in wound-healing assays, diminished lamelli-
podial ruffling, decreased macropinocytosis, and a striking cell 
polarity phenotype characterized by multiple leading edges that 
pull the cell in different directions (Liang et al., 2009). In addition, 
CARMIL2 was found to localize to vimentin intermediate filaments 
(Liang et al., 2009), the significance of which has not been 
addressed.
The connection of CARMIL2 to vimentin is intriguing, because 
vimentin appears to play a critical role in actin-based cell migration. 
First, vimentin expression is a hallmark of the epithelial–mesenchy-
mal transition in metastatic carcinomas, correlating with the migra-
tion and invasion potential of cancer cells (Gilles et al., 1999; Eckes 
et al., 2000; Savagner, 2010; Rogel et al., 2011; Satelli and Li, 2011; 
Menko et al., 2014). Second, vimentin filaments have been function-
ally linked to processes that require coordination of the actin net-
work during cell migration and invasion (Schoumacher et al., 2010; 
Helfand et al., 2011; Sakamoto et al., 2013; Sutoh Yoneyama et al., 
2014; Havel et al., 2015). However, the mechanisms by which vimen-
tin influences actin-based cell motility remain poorly understood. 
We reasoned that CARMIL2 was a strong candidate to connect the 
vimentin and actin filament systems, because CARMIL2 localizes to 
vimentin in cells and can regulate actin polymerization through its 
interaction with CP.
In this study, we investigated the physiological relevance of 
localization to vimentin and binding to CP with respect to the role 
of CARMIL2 in cell migration and invadopodia formation. We ob-
served CARMIL2 localization to dynamic vimentin filaments at the 
leading edges of cells, identified the vimentin-localizing region of 
CARMIL2, and characterized the biochemical interaction be-
tween CARMIL2 and CP. Most important, using expression of 
specific mutants and chimeras, we found that both localization to 
vimentin and the ability to bind CP are completely necessary for 
function, including invadopodia formation as assayed by matrix 
degradation.
FIGURE 1: CARMIL2 localizes to dynamic vimentin filaments at the 
leading edge of migrating cells. (A) Domain map of CARMIL2. 
(B) Localization of expressed CARMIL2-GFP, compared with vimentin 
and F-actin, in the top panels. Arrow, example of colocalization of 
CARMIL2-GFP with vimentin; arrowhead: example of CARMIL2-GFP 
localization in leading-edge ruffles. Bottom panels show a negative 
control with expressed GFP. (C) Dynamics of expressed vimentin-
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tdTomato in frames from live-cell movies (Supplemental Movies S1 
and S2). Arrowheads, examples of dynamic vimentin filaments at the 
leading edge. (D) Colocalization of CARMIL2-GFP with dynamic 
vimentin-tdTomato filaments at the leading edge (arrowheads). 
Frames from a live-cell movie (Supplemental Movie S3). Scale bars: 
10 μm. (E) Kymograph of vimentin filament boxed in yellow from 
panel D.
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full-length protein. A chimera composed of the PH domain of CAR-
MIL1 (PH1) with the LRR domain of CARMIL2 (LRR2) and the C-Term 
of CARMIL1 (C-Term1), PH1/LRR2/C-Term1, localized to vimentin 
filaments, whereas the converse chimera, PH2/LRR1/C-Term2, local-
ized to the leading-edge membrane, including ruffles (Figure 2B). 
We conclude that information in the LRR domain of CARMIL2 is 
necessary and sufficient for localization with vimentin in the context 
of full-length CARMIL or the N-Term of CARMIL.
We further divided the LRR domain, which consists of 16 LRRs. 
The LRR domain has a highly conserved region in the eighth repeat, 
on the ascending loop between the β-strand and α-helix (Zwolak 
et al., 2013). Using this location as a splice site, we observed that 
chimeras with the first eight LRRs of CARMIL2 (LRRN2) and the sec-
ond eight LRRs of CARMIL1 (LRRC1), expressed in the context of the 
N-Term of CARMIL, localized to vimentin; however, the degree of 
localization to vimentin for these split constructs was not as strong 
as for those chimeras with all 16 LRRs from CARMIL2. Thus the first 
eight LRRs are more important for localization to vimentin than the 
second eight LRRs, but the second eight repeats do make a notice-
able contribution.
To quantify colocalization with vimentin, we calculated the Man-
ders overlap coefficients for the CARMIL2 truncations and chimeras 
(Figure 2C). In support of the qualitative observations, the values 
revealed that truncations and chimeras containing the LRR domain 
of CARMIL2 overlapped significantly more with vimentin than con-
structs that did not. Chimeras with the first eight LRRs displayed in-
termediate levels of overlap with vimentin filaments, also consistent 
with the qualitative observations.
To extend the analysis, we collected dual-label movies of living 
migrating cells and examined localization patterns for full-length 
CARMIL-GFP chimeras with vimentin-tdTomato (Figure 2D and Sup-
plemental Movies S4–S9), using heat-map pseudocoloring of CAR-
MIL2-GFP. Wild-type CARMIL2-GFP was observed on dynamic vi-
mentin filaments, as noted above. Localization to vimentin was 
found with the PH1/LRR2/C-Term1 chimera but not the PH2/LRR1/
C-Term2 chimera, which localized to leading-edge membranes and 
ruffles. The N-Term of CARMIL2 localized with vimentin, and the C-
Term localized to leading-edge membrane ruffles. Thus the movie 
analysis of living cells confirmed the previous single-image results, 
in every respect.
CARMIL2 mutant unable to bind CP
Human CARMIL2, like all vertebrate CARMILs, contains a domain 
called the CP-binding region (CBR), which includes two tandem CP-
binding motifs: CPI and CSI (Figure 1A; Hernandez-Valladares et al., 
2010; Edwards et al., 2014). For CARMIL1, biochemical studies 
showed that the CBR region is sufficient to bind CP and decrease 
the actin-capping activity of CP (Yang et al., 2005; Fujiwara et al., 
2010; Hernandez-Valladares et al., 2010; Zwolak et al., 2010; Kim 
et al., 2012; Edwards et al., 2013). This ability had not been tested 
for any CARMIL2 isoform, so we performed the relevant assays here 
for human CARMIL2, using the putative CBR, consisting of Pro-961 
to Arg-1072.
First, we tested the ability of CARMIL2-CBR to inhibit actin cap-
ping by CP in a pyrene-actin–seeded polymerization assay. In this 
assay, CP inhibits polymerization of actin by binding to the barbed 
ends of growing filaments. Inhibition by CP was relieved with in-
creasing concentrations of CARMIL2-CBR (Figure 3A). Kinetic mod-
eling with a simple 1:1 mechanism for CBR binding to CP (reaction 3, 
Materials and Methods section) fitted the data well, yielding an 
apparent Kd of 2.9 ± 0.4 nM. Second, we tested the ability of 
CARMIL2-CBR to uncap actin filaments that are capped by CP, 
RESULTS
CARMIL2 localizes to dynamic vimentin filaments at leading 
edges
We examined the mechanism and significance of the colocalization 
of CARMIL2 with vimentin and hypothesized that CARMIL2 links vi-
mentin filaments with actin assembly at the membrane. We then 
asked whether CARMIL2 localizes to dynamic vimentin filaments at 
the edges of cells, where actin assembly is dynamic. First, using ex-
pressed CARMIL2–green fluorescent protein (GFP), we confirmed 
colocalization of CARMIL2 with the bulk of vimentin filaments in the 
central cytoplasm, accompanied by localization of CARMIL2 in lead-
ing-edge ruffles (Figure 1B). Next we imaged individual vimentin 
filaments at the edge of migrating HT1080 cells, using expressed 
vimentin-tdTomato. We found that vimentin formed highly dynamic, 
thin, filamentous structures in close proximity to the plasma mem-
brane (Figure 1C and Supplemental Movies S1 and S2), consistent 
with findings in other motile cells (Helfand et al., 2011; Sakamoto 
et al., 2013; Havel et al., 2015). We observed motile filaments of vi-
mentin at the leading edge, extending toward and retracting away 
from the membrane.
To determine whether CARMIL2 localized to these dynamic 
vimentin filaments, we coexpressed CARMIL2-GFP with vimentin-
tdTomato. In live-cell movies of single migrating cells, CARMIL2-GFP 
colocalized along the length of dynamic vimentin filaments at the 
leading edge (Figure 1D and Supplemental Movie S3). Heat-map 
pseudocoloring was used to show enrichment of CARMIL2-GFP on 
vimentin filaments. To investigate the timing of vimentin-filament re-
traction and extension with respect to CARMIL2 colocalization along 
filaments, we created kymographs, drawing lines along vimentin fila-
ments (Figure 1E). Vimentin and CARMIL2 dynamics were coincident 
in time, consistent with CARMIL2 bound to vimentin filaments that 
extend and retract by trafficking along microtubules via microtubule 
motors, a model previously described by others (Gyoeva and Gel-
fand, 1991; Prahlad et al., 1998; Helfand et al., 2002).
CARMIL2-LRR is necessary and sufficient for localization 
to vimentin
To create probes for testing the functional significance of localiza-
tion to vimentin by CARMIL2, we first identified regions of CARMIL2 
necessary and sufficient for localization to vimentin. We used GFP 
fusions of CARMIL2 truncations and chimeras of CARMIL2 with 
CARMIL1, with truncation and fusion sites determined from second-
ary structure predictors (PSIPRED) and the CARMIL1 crystal structure 
(Zwolak et al., 2013; Figure 2A). First, we observed that the N-termi-
nal half of CARMIL2 (N-Term) localized with vimentin, but the C-
terminal half (C-Term) did not. Instead, the C-Term of CARMIL2 lo-
calized to leading-edge membranes, including ruffles (Figure 2B). 
Dividing the N-Term further, we found that localization to vimentin 
was seen with the LRR domain and not with the PH domain 
(Figure 2B). Smaller fragments were not tested, because they were 
not expected to be stable, based on previous biochemical studies 
(Zwolak et al., 2013).
Next we constructed chimeras between CARMIL1 and CARMIL2, 
interchanging the PH domains, the LRR domains, and the C-Terms 
of each protein. Splice sites were determined using sequence align-
ments and the CARMIL1 crystal structure to avoid disrupting sec-
ondary structures. Chimeras were created and cloned into GFP-fu-
sion expression vectors using Gibson assembly (Gibson, 2011). First, 
we tested chimeras composed of domains from the N-Term of the 
protein. The PH domain of CARMIL1 fused to the LRR domain of 
CARMIL2 (PH1/LRR2) localized to vimentin, while the converse con-
struct, PH2/LRR1, did not. Next we tested chimeras consisting of 
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tures of CARMIL1-CBR with CP show several close contacts between 
the CPI motif and CP (Hernandez-Valladares et al., 2010). In previ-
ous work with CARMIL1, we found that changing two basic residues, 
K987 and R989, to alanine led to a nearly complete loss of binding 
(Edwards et al., 2013). We mutated the analogous residues of CAR-
MIL2-CBR, R985 and R987, to alanine. Repeating the pyrene-actin–
seeded polymerization assays, we found that the mutant had little to 
no ability to interact with CP, either in the assay for inhibition of 
capping (Figure 3C) or the assay for uncapping (Figure 3D).
These assays were performed with the CBR fragment, using puri-
fied proteins in vitro. In a complementary approach, we tested the 
another known property of CARMIL1 (Yang et al., 2005; Hernandez-
Valladares et al., 2010; Kim et al., 2012; Edwards et al., 2013). We 
modified the pyrene-actin–seeded polymerization assay by adding 
CARMIL2-CBR after, not before, the actin barbed ends were capped 
by CP. The rate of actin polymerization increased rapidly, consistent 
with uncapping (Figure 3B). We conclude that CARMIL2 binds and 
inhibits CP, with a level of activity similar to that observed previously 
for CARMIL1 (Kim et al., 2012).
Next we created a CARMIL2 mutant defective in binding CP, by 
changing two amino acid residues. CARMIL2 contains a CPI motif, 
defined as LxHxTxxRPK(x)6P (Bruck et al., 2006), and cocrystal struc-
FIGURE 2: LRR domain of CARMIL2 is necessary and sufficient for localization to vimentin. (A) Domain map of CARMIL2 
indicating CARMIL2 truncations and CARMIL1/CARMIL2 chimeras, along with summary of localization to vimentin 
results. (B) Localization of CARMIL-GFP fusion proteins compared with vimentin-tdTomato. (C) Manders overlap 
coefficients for expressed CARMIL2-GFP fusion proteins and vimentin-tdTomato. Number of data points as follows: GFP, 
2; CARMIL2, 4; N-Term, 5; C-Term, 4; PH, 4; LRR, 3; PH1/LRR2/C-Term1, 5; PH2/LRR1/C-Term2, 4; PH1/LRR2, 5; PH2/
LRR1, 5; PH1/LRRN1/LRRC2, 4; PH1/LRRN2/LRRC2, 4; PH2/LRRN2/LRRC1, 5; PH2/LRRN1/LRRC2, 5. Statistical 
significance as follows: *, p < 0.05; **, p < 0.01; ***, p < 0.001. (D) Initial frame of movies (Supplemental Movies S4–S9) 
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cells and cells infected with a scramble-sequence shRNA served as 
negative controls. In the movies, CARMIL2-depleted cells exhibited 
a polarity defect, with multiple protrusions pulling the cell in many 
directions (Figure 4B), as previously described (Liang et al., 2009). 
The leading edges of CARMIL2-depleted cells were smooth and 
flat, lacking the prominent lamellipodia and membrane ruffles seen 
in the controls. In addition, the depleted cells formed few macropi-
nosomes, consistent with the loss of ruffles, which mediate macropi-
nosome formation (Kerr and Teasdale, 2009).
We quantitated the cell polarity defect by calculating the circu-
larity of the cell (Figure 4C), defined as the area of the cell divided 
by the area of a circle with the same perimeter as the cell (see 
Materials and Methods). We quantitated macropinocytosis by 
counting the number of macropinosomes per cell (Figure 4D). Loss 
of CARMIL2 led to statistically significant moderate decreases in the 
value of circularity and large decreases in the number of macropino-
somes (Figure 4, C and D).
To test for rescue by expression, we first confirmed that all of the 
traits of the CARMIL2-depletion phenotype could be rescued by 
expression of shRNA-resistant wild-type CARMIL2, demonstrating 
that the effects of the shRNA were specific for CARMIL2, without 
off-target effects (Figure 4, B–D).
We found that expression of the CARMIL chimera PH2/LRR1/C-
Term2, which does not localize to vimentin, did not rescue any of 
the traits of the loss-of-function phenotype (Figure 4, B–D). How-
ever, expression of the converse chimera, PH1/LRR2/C-Term1, 
which does localize to vimentin, was able to provide full rescue 
(Figure 4, B–D). Thus localization to vimentin is necessary for the 
function of CARMIL2 in cells. The results with the converse chimera 
show that providing CARMIL1 with the ability to localize to vimentin 
(by changing the LRR domain) is sufficient to allow CARMIL1 to sub-
stitute for CARMIL2. Thus the LRR of CARMIL2 has a specific and 
essential function, while the functions of the other domains are simi-
lar for CARMIL1 and CARMIL2.
Expression of the CP-binding mutant did not rescue any of the 
traits caused by loss of CARMIL2 (Figure 4, B–D). Thus the ability of 
CARMIL2 to bind CP is also completely necessary for its function.
To quantify single-cell migration, we calculated the persistence, 
distance traveled, and mean-square displacement of randomly mi-
grating individual cells. We found no differences between un-
treated, CARMIL2-depleted, or any of the rescue conditions 
(Figure 4, E–G). From these results, we concluded that loss of 
CARMIL2 has no effect on single-cell migration in the absence of 
a directional cue.
Next, to investigate the hierarchy of the molecular interactions, 
we examined the vimentin and lamellipodial actin networks in the 
depletion and expression-rescue cells by staining cells with anti-vi-
mentin, anti-CP, and fluorescent phalloidin. The vimentin filament 
networks were similar in all cases (Figure 4H). In contrast, disruptions 
of the lamellipodial actin network were observed when CARMIL2 
function was not present. Anti-CP staining, which in control cells was 
prominent at the leading edge and in puncta surrounding macropi-
nosomes, was greatly diminished at those locations in cells lacking 
CARMIL2 (Figure 4H). The CP-staining pattern was rescued by ex-
pression of shRNA-resistant wild-type CARMIL2 and the PH1/LRR2/
C-Term1 chimera, whereas the staining pattern of the PH2/LRR1/C-
Term2 chimera and the RR985/987AA CP-binding mutant resembled 
CARMIL2-depleted cells. Examination of the F-actin network with 
fluorescent phalloidin yielded similar results (Figure 4H). CARMIL2-
depleted cells showed decreased phalloidin staining, and this was 
rescued by expression of the PH1/LRR2/C-Term1 chimera but not 
the PH2/LRR1/C-Term2 chimera or the RR985/987AA CP-binding 
ability of full-length CARMIL2, wild-type and mutant, to interact with 
CP in HT1080 cells by immunoprecipitation. We found that CP 
coprecipitated with FLAG-tagged wild-type CARMIL2. In contrast, 
CP did not coprecipitate with the RR985/987AA mutant form of 
FLAG-CARMIL2 (Figure 3E). On the basis of these results, we con-
clude that the interaction of CARMIL2 with CP was essentially lost in 
the RR985/987AA mutant.
The physiological significance of CARMIL2 interaction with 
vimentin and CP
We used the CARMIL2/CARMIL1 chimeras and the CARMIL2 
RR985/987AA mutant to test the physiological significance of local-
ization to vimentin and CP binding for the function of CARMIL2. We 
asked whether expression of the chimeras or the mutant was able to 
rescue traits that result from loss of CARMIL2 (Liang et al., 2009). To 
deplete endogenous CARMIL2, we used a lentiviral system to de-
liver short hairpin RNA (shRNA) targeting CARMIL2. A second lenti-
virus was used to introduce shRNA-resistant versions of GFP fusions 
of the chimeras and mutants. Immunoblots confirmed that endog-
enous CARMIL2 was depleted and that the expression levels of the 
rescue constructs were appropriate (Figure 4A).
We first examined the cell polarity, lamellipodial assembly, ruf-
fling, and macropinocytosis defects resulting from loss of CARMIL2 
(Liang et al., 2009). Phase-contrast movies of individual, randomly 
migrating CARMIL2-depleted and expression-rescue cells were col-
lected (Figure 4B and Supplemental Movies S10–S16). Uninfected 
FIGURE 3: CARMIL2 mutant RR985/987AA loses ability to bind CP. 
(A) Inhibition of capping activity by CBR fragment of wild-type 
CARMIL2 in pyrene-actin–seeded polymerization assay. CBR and CP 
were mixed before time zero. (B) Reversal of capping by CBR 
fragment of wild-type CARMIL2 in a similar assay. CP was added at 
time zero, and CARMIL2-CBR was added at 200 s (arrowhead). 
(C) CARMIL2 RR985/987AA mutant fails to inhibit capping activity and 
(D) fails to reverse capping, in experiments similar to those in A and B. 
(E) Full-length CARMIL2 RR985/987AA mutant does not interact with 
CP in whole-cell lysates. FLAG-tagged full-length CARMIL2, wild-type, 
and RR985/987AA mutant, was precipitated from whole-cell lysates. 
Precipitates were probed with anti-CP, anti-FLAG, and anti-GAPDH.
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FIGURE 4: Localization to vimentin and CP-binding ability of CARMIL2 are necessary for lamellipodial ruffling, 
macropinocytosis, and cell polarity. (A) Expression of CARMIL-GFP mutants and chimeras to test for rescue of loss of 
CARMIL2. Immunoblots of whole-cell lysates probed with anti-CARMIL2, anti-GFP, and anti-GAPDH. (B) Cell polarity 
phenotype revealed in images. First frame of 1-h movies (Supplemental Movies S10–S16) of migrating cells plated 
sparsely. PH2/LRR1/C-Term2 chimera and RR985/987AA CP-binding mutant fail to rescue effects of depletion of 
CARMIL2; however, rescue is provided by wild-type CARMIL2 and the PH1/LRR2/C-Term1 chimera. Scale bar: 10 μm. 
(C) Quantification of cell polarity from the images based on calculation of circularity, as described in Materials and 
Methods, for CARMIL2-depletion and expression-rescue cells (n = 30). *, p < 0.0001. Box-and-whisker format showing 
median, interquartile range, and the extremes. (D) Quantification of macropinocytosis based on counting 
macropinosomes in CARMIL2-depletion and expression-rescue cells (n = 30). Error bars are SEM. *, p < 0.0001. 
(E) Persistence of individually migrating cells (n = 30). Error bars are SEM. (F) Distance traveled of individually migrating 
cells (n = 30). Error bars are SEM. (G) Mean-squared displacement of individually migrating cells (n = 30). Error bars are 
SEM. (H) Assembly of the lamellipodial actin network, but not the vimentin network, at the cell edge depends on ability 
of CARMIL2 to localize to vimentin and to bind CP. CARMIL2-depleted and expression-rescue cells were stained with 
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Invadopodia formation and matrix degradation
Vimentin filaments have been proposed to play a role in the forma-
tion of invadopodia (Schoumacher et al., 2010; Sutoh Yoneyama 
et al., 2014). Invadopodia are filled with dynamic actin filament net-
works nucleated by the Arp2/3 complex (Buccione et al., 2004; 
Lorenz et al., 2004; Yamaguchi et al., 2005; Weaver, 2006). We hy-
pothesized that CARMIL2 might serve as a molecular link connect-
ing vimentin to actin assembly in invadopodia. To assay invadopo-
dia formation, we performed matrix-degradation assays by imaging 
the loss of fluorescent matrix under HT1080 cells. In control cells, 
sites of matrix degradation were found in association with bright 
puncta of F-actin, which are the defining hallmarks of invadopodia 
(Figure 6A; Chen, 1989). In contrast, sites of matrix degradation 
were absent in CARMIL2-depleted cells, based on qualitative obser-
vations of images and a quantitative method of image analysis that 
involved converting the fluorescent-matrix image to a binary format 
(Figure 6B; see Materials and Methods). The matrix-degradation 
phenotype was rescued by expression of wild-type CARMIL2 and 
the PH1/LRR2/C-Term1 chimera, but not the PH2/LRR1/C-Term2 
chimera or the RR985/987AA CP-binding mutant. On the basis of 
mutant. On the basis of these results, we conclude that the abilities 
of CARMIL2 both to localize to vimentin and to bind CP are neces-
sary for lamellipodial actin assembly, membrane ruffling, macro-
pinocytosis, and cell polarity.
Collective cell migration depends on localization to vimentin 
but not CP-binding ability
We investigated the importance of the individual biochemical and 
cellular functions of CARMIL2 for the process of cell migration in 
wound healing. Cell migration defects in wound-healing assays 
have been described for cells lacking CARMIL2 (Liang et al., 
2009). Here we first confirmed that CARMIL2-depleted cells mi-
grate slowly, compared with control cells, when they fill a scratch 
wound in a tissue-culture monolayer (Figure 5A). The rate of 
movement of the edge of the monolayer was decreased by al-
most half (Figure 5B).
We found that expression of wild-type CARMIL2 and the PH1/
LRR2/C-Term1 chimera rescued the migration defect completely 
(Figure 5, A and B); however, expression of the PH2/LRR1/C-Term2 
chimera had no effect. Thus the ability of CARMIL2 to interact with 
vimentin is necessary for the function of CARMIL2 in cell migration 
in wound healing.
In a surprising contrast, expression of the CP-binding mutant 
RR985/987AA rescued the cell migration defect completely (Figure 
5, A and B), which was not the case for all the other loss-of-function 
traits discussed above, including cell polarity, lamellipodial assem-
bly, ruffling, and macropinocytosis. Thus the absence of lamellipo-
dia and ruffling in the CP-binding mutant cells had no effect on the 
rate of cell migration, indicating that these prominent dynamic fea-
tures of the leading edge are not important for cell migration in the 
context of wound healing. This conclusion is consistent with other 
studies of cells with impaired lamellipodial assembly created by 
other perturbations (Gupton et al., 2005; Suraneni et al., 2012; Wu 
et al., 2012; Edwards et al., 2013).
Together these results lead us to two conclusions. First, the local-
ization to vimentin function of CARMIL2, but not the ability to bind 
CP, is necessary for collective cell migration. Second, lamellipodia 
and ruffles are dispensable for cell migration in the wound-healing 
setting.
FIGURE 5: Cell migration in wound-healing assay depends on the 
ability of CARMIL2 to localize to vimentin but not its ability to bind 
CP. (A) Distance traveled from edge of wound by CARMIL2-depleted 
and expression-rescue cells over time. Error bars on plotted points 
are SEM. (B) Average migration speed of CARMIL2-depleted and 
expression-rescue cells during wound-healing assays. Data are the 
mean of nine repetitions of each experiment collected on the same 
day; error bars are SEM. *, p < 0.0001.





















































































FIGURE 6: Invadopodia formation and degradation of underlying 
matrix depends on abilities of CARMIL2 to localize to vimentin and to 
bind CP. (A) Uninfected cells and CARMIL2-depleted cells plated on 
fluorescent gelatin. Invadopodia (arrowheads) are identified with 
fluorescent phalloidin staining. Sites of matrix degradation are 
identified as dark areas in the fluorescent gelatin image. For 
quantification, the fluorescent gelatin image was converted with a 
threshold set at 3 SDs below mean pixel intensity. Scale bar: 10 μm. 
(B) Quantification of matrix degradation. Mean percent of cell area with 
matrix degradation in threshold images for CARMIL2-depletion and 
expression-rescue cells. Error bars are SEM. n = 20 cells. *, p < 0.0001.
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assays. Vimentin expression is a hallmark of the epithelial–mesenchy-
mal transition of carcinomas, correlating with the potential for cancer 
cells to migrate and invade (Gilles et al., 1999; Eckes et al., 2000; 
Savagner, 2010; Rogel et al., 2011; Satelli and Li, 2011; Menko et al., 
2014), so CARMIL2 may be a critical link that connects vimentin to 
invasion and migration of cancer cells.
In contrast to collective cell migration, random migration of in-
dividual cells is not affected by loss of CARMIL2. Collective cell 
migration depends on guidance of leader cells and cooperation of 
follower cells. This is mediated by localization of key proteins, such 
as Rac1, to the leading edge and transduction of migrational cues 
through cell–cell junctions, respectively (Friedl, 2004; Dumortier 
et al., 2012; Collins and Nelson, 2015; Haeger et al., 2015; 
Yamaguchi et al., 2015). CARMIL2 depletion does not disrupt the 
ability of cells to maintain contact during wound healing, and the 
overall levels of Rac1 activation are not decreased in CARMIL2-
depleted cells (Liang et al., 2009). However, the localization of ac-
tivated Rac1 in CARMIL2-depleted cells may be impaired during 
wound healing. If so, then localization of active Rac1 would de-
pend on the ability of CARMIL2 to localize to vimentin but not 
bind CP. Elucidating the differences in the role of CARMIL2 be-
tween random and directed migration requires further study.
One striking result was that replacement of the LRR domain of 
CARMIL1 with the vimentin-localizing LRR domain of CARMIL2 was 
sufficient to rescue CARMIL2 phenotypes. Thus the other domains 
of CARMIL1, including the noncanonical PH domain, the CBR, the 
basic and hydrophobic membrane-binding domain (Brzeska et al., 
2010), and the PRD, have sufficient functional overlap to replace the 
corresponding domains of CARMIL2. Only the LRR domain has a 
specific function unique to CARMIL2. Of note, the chimera of 
CARMIL2 with the CARMIL1 LRR (PH2/LRR1/C-Term2) localizes to 
the leading edge but is not able to rescue the lamellipodial defects 
of CARMIL2-depleted cells. This observation suggests that the key 
function of CARMIL2 is to provide a functional connection between 
vimentin filaments and membrane-associated actin during cell mi-
gration and invasion.
We investigated the physiological significance of the ability of 
CARMIL2 to bind and inhibit CP, which has been established for 
CARMIL1 (Edwards et al., 2013). We found that the apparent affin-
ity for CARMIL2 binding to CP was similar to that of CARMIL1 
(Hernandez-Valladares et al., 2010; Kim et al., 2012), consistent 
with the sequence similarities and the cocrystal structures. In addi-
tion, we found a mutant form of CARMIL2 with a nearly complete 
loss of the ability to bind CP was unable to rescue the loss of la-
mellipodial ruffling, macropinocytosis, cell polarity, and invadopo-
dia-mediated matrix degradation. Thus the ability to bind CP is 
necessary for the function of CARMIL2 in cells, as is the case for 
CARMIL1 (Edwards et al., 2013). This result supports the hypothe-
sis that CP binding is one critical function, held in common by 
CARMIL1 and CARMIL2, that is targeted to vimentin filaments by 
CARMIL2.
On the other hand, the CARMIL2 CP-binding mutant was able 
to rescue the wound-healing cell migration defect of CARMIL2-
depleted cells. These cells lack lamellipodia, so this result provides 
additional evidence that lamellipodia are dispensable for cell mi-
gration in certain contexts (Gupton et al., 2005; Suraneni et al., 
2012; Wu et al., 2012). A similar result was obtained for CARMIL1 
(Edwards et al., 2013); therefore another function of CARMIL1 and 
CARMIL2 must be necessary for cell migration in wound healing. 
That function may be binding to membranes, which is mediated 
by a basic and hydrophobic membrane-binding domain, as de-
scribed by us in a separate study (Lanier et al., 2015).
these results, we conclude that the ability of cells to degrade matrix 
depends on CARMIL2’s ability to interact with vimentin and bind CP.
DISCUSSION
In this study, we report the discovery of a novel molecular connec-
tion between vimentin intermediate filaments and lamellipodial ac-
tin dynamics. First, we found that CARMIL2 localizes to dynamic vi-
mentin filaments at the leading edges of migrating cells, mediated 
by its LRR domain. We showed that CARMIL2 binds and inhibits CP, 
similar to other CARMILs. Most important, we created mutants and 
chimeras with specific functional properties, which demonstrate that 
both localization to vimentin and the CP-binding ability of CARMIL2 
are necessary for the function of CARMIL2 in invadopodia formation 
and cell migration, hallmarks of malignant cancers.
CARMIL family proteins have similar domain architectures, with a 
high degree of sequence similarity throughout (Liang et al., 2009; 
Zwolak et al., 2013). However, the three vertebrate isoforms possess 
highly conserved differences that distinguish one from another (Ed-
wards et al., 2014), suggesting that they have different functions. 
Our previous work revealed that CARMIL1 and CARMIL2 have dif-
ferent localizations and functions in cultured human cells. Most im-
portant, expression of one was not able to rescue phenotypes re-
sulting from loss of the other (Liang et al., 2009).
CARMIL2 is known to colocalize with vimentin filaments (Liang 
et al., 2009). However, the physiological significance and mecha-
nism of the interaction was not known. In addition, the extent of 
colocalization was not examined, especially whether CARMIL2 colo-
calized with dynamic vimentin filaments at the cell edge. Vimentin 
filaments at the leading edge are particularly interesting because of 
evidence linking vimentin to processes of membrane-associated ac-
tin assembly, including the formation of cell protrusions, notably in-
vadopodia, which are features of cancer cells invading tissue (Schou-
macher et al., 2010; Helfand et al., 2011; Sakamoto et al., 2013; 
Sutoh Yoneyama et al., 2014; Havel et al., 2015).
To investigate the mechanism and significance of the vimentin–
CARMIL2 interaction, we first identified the LRR domain of CAR-
MIL2 as necessary and sufficient for localization to vimentin. LRR 
domains of other proteins, including NOD2 and NLRP3, also inter-
act with vimentin (Stevens et al., 2013; dos Santos et al., 2015), but 
we found no obvious sequence or structural similarities between 
those LRR domains and the LRR domain of CARMIL2. To test the 
physiological significance of CARMIL2’s localization to vimentin, we 
created chimeras with specific loss or gain of vimentin interaction by 
exchanging LRR domains between CARMIL1 and CARMIL2. Our re-
sults show that the ability to interact with vimentin is completely 
necessary for CARMIL2 to function and that addition of this ability to 
CARMIL1 is sufficient to allow CARMIL1 to function in place of 
CARMIL2.
Loss of CARMIL2 causes a number of phenotypes (Liang et al., 
2009). We found that PH2/LRR1/C-Term2, the chimera that does not 
localize to vimentin, was unable to rescue defects in lamellipodia, 
ruffling and macropinocytosis; these membrane-associated phe-
nomena depend on one another and on actin assembly (Chhabra 
and Higgs, 2007; Kerr and Teasdale, 2009). This chimera was also 
unable to rescue the distinctive cell polarity defect displayed by 
CARMIL2-depleted cells, which resembles the polarity defects of 
cells lacking myosin-IIB, Cdc42, or PAK1 (Nobes and Hall, 1999; 
Sells et al., 1999; Lo et al., 2004; Cau and Hall, 2005; Liang et al., 
2009; Parrini et al., 2009).
We also found that localization to vimentin is important for CAR-
MIL2’s role in collective cell migration, based on wound-healing as-
says, and for formation of invadopodia, based on matrix-degradation 
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anti-GFP 6C5 and mouse mAb anti-GAPDH (Abcam, Cambridge, 
MA); and Alexa Fluor–conjugated secondary antibodies (Life Tech-
nologies, Carlsbad, CA). To stain for F-actin, we used Alexa Fluor–
conjugated phalloidin (Sigma-Aldrich).
Cell culture, transfection, knockdown, and rescue 
of CARMIL2
Plasmids are listed in Supplemental Table S1. Human CARMIL2b 
cDNA (NCBI: FJ026014) and CARMIL1a (NCBI: FJ009082) were the 
starting materials for all subcloning and chimera construction. GFP 
fusions were created by subcloning CARMIL2 and fragments into 
pAcGFP1-C1 (Clontech, Mountain View, CA) at BglII and HindIII 
sites. CARMIL chimeras were created using Gibson assembly 
methods (Gibson, 2011). For fragments and chimeras, truncation 
and splice sites were chosen based on PSIPRED and alignments 
with the mouse CARMIL1 structure of Zwolak et al. (2013). Adam 
Zwolak and Roberto Dominguez of the University of Pennsylvania 
provided critical advice on selecting sites to produce stable frag-
ments. For chimeras, domain boundaries were as follows: PH1 
1-147; PH2 1-148; LRR1 148-684; LRR2 149-687; C-Term1 685-
1371; C-Term2 688-1372. Vimentin (NCBI: NM_003380) was sub-
cloned into tdTomato-N1 at the BglII and HindIII sites.
Human HT1080 cells (American Type Culture Collection, 
Manassas, VA) were grown in DMEM (Life Technologies, Grand Is-
land, NY) supplemented with 10% fetal bovine serum (Sigma-
Aldrich) at 37°C with 5% CO2. Cells were transfected using Transit-
LT1 (Mirus, Madison, WI).
For depletion of endogenous CARMIL2, an shRNA construct tar-
geting CARMIL2, in the lentiviral vector pFLRu-FH-GFP, was used 
as previously described (Liang et al., 2009). The shRNA targeting 
sequence was GCAAAGATGGCGAGATCAAG, with CAGTCGC-
GTTTGCGACTGG as a nontargeting scrambled control. For expres-
sion rescue, shRNA-resistant CARMIL2 constructs were subcloned 
into pBOB-GFP for lentiviral-based expression as described (Mooren 
et al., 2014). Resistance to shRNA was created with three codon-si-
lent nucleotide changes (lowercase): GCAAgGAcGGgGAGAT-
CAAG, using QuikChange mutagenesis (Stratagene, La  Jolla, CA). 
The CARMIL2 RR985/987AA CP-binding mutant was created using 
QuikChange site-directed mutagenesis (Stratagene).
Immunofluorescence, live-cell imaging, and image analysis
For immunofluorescence, HT1080 cells grown on glass coverslips 
coated with 30 μg/ml fibronectin (Sigma-Aldrich) were fixed 24 h 
posttransfection. For staining with fluorescent phalloidin or antibod-
ies, cells were generally fixed in 2.5% paraformaldehyde and 0.25% 
glutaraldehyde in PIPES buffer (125 mM NaCl, 5 mM KCl, 1.25 mM 
NaH2PO4, 0.4 mM KH2PO4, 1 mM MgCl2, 5.5 mM glucose, 0.5 mM 
ethylene glycol tetraacetic acid, 20 mM 1,4-piperazinediethanesul-
fonic acid, pH 7.1) at 37°C for 10 min, then quenched with 1 mg/ml 
NaBH4 in Dulbecco’s phosphate-buffered saline (pH 7.1). Cells were 
permeabilized with 0.1% Triton X-100 at room temperature for 
10 min. Different fixation protocols were used for vimentin (ice-cold 
MeOH at −20°C for 10 min) and CP (GlyoFixx at 37°C for 10 min; 
Thermo-Scientific, Kalamazoo, MI). Immunostaining was performed 
with the primary and secondary antibodies listed above. Cells were 
imaged using 60×/1.4 numerical aperture (NA) and 100×/1.4 NA 
objectives on an Olympus IX70 inverted microscope (Olympus, Mel-
ville, NY). Wide-field images were collected with a CoolSnap HQ 
camera (Photometrics, Woburn, MA), and spinning-disk confocal 
images were collected with an Orca Flash 4.0 camera (Hamamatsu, 
Bridgewater, NJ). Images were collected and initially processed with 
Micromanager (Edelstein et al., 2010) and ImageJ.
The interaction of CARMIL2-CBR with CP decreased, but did not 
eliminate, the ability of CP to bind barbed ends, as is the case for 
CPI-motif proteins in general (Hernandez-Valladares et al., 2010; 
Kim et al., 2012; Edwards et al., 2014). Thus CARMIL2 may have a 
role in targeting CP to sites of actin assembly and in modulating its 
capping activity, bringing it down to a level appropriate for a physi-
ological setting (Yang et al., 2005; Uruno et al., 2006). Consistent 
with this view, a recent study from our lab revealed that the interac-
tion of CP with a CPI-motif protein is necessary for the function of CP 
in cells (Edwards et al., 2015). In that study, expression of CP with 
point mutations that ablate its interaction with the CPI motif caused 
loss-of-function phenotypes in dominant-negative and expression-
rescue experiments. One model for how CP may be activated by a 
CPI motif is that CP may be constitutively inhibited by the protein 
V1/myotrophin and that CPI-motif proteins relieve that inhibition by 
an allosteric mechanism (Fujiwara et al., 2014).
On the basis of these results, we propose a model of CARMIL2 
function in which vimentin filaments target CARMIL2 and its domains, 
including the CBR, basic and hydrophobic membrane-binding do-
main, PH domain, and PRD, to critical membrane-associated sites for 
lamellipodia formation, cell migration, and invadopodia-mediated 
matrix degradation. (Figure 7). The properties of this novel multifunc-
tional multidomain protein provide new insight into the molecular 
mechanisms that underlie cancer cell invasion and migration.
MATERIALS AND METHODS
Antibodies and reagents
Reagents and materials were from Sigma-Aldrich (St. Louis, MO) or 
Fisher Scientific (Pittsburgh, PA), unless stated otherwise. To detect 
CARMIL2 protein, we produced a rabbit polyclonal antibody (pAb) 
against a peptide consisting of amino acid residues 665–678 (HP-
TRARPRPRRQHH). To detect vimentin by immunostaining, we 
used mouse monoclonal antibody (mAb) 3B4 (Millipore, Billerica, 
MA). Other antibodies were as follows: mouse mAb anti-Flag M2 
and horseradish peroxidase–conjugated secondary antibodies 
(Sigma-Aldrich); mouse mAb anti-CP 2A3 (Developmental Studies 
Hybridoma Bank, University of Iowa, Iowa City, IA); rabbit pAb 
FIGURE 7: Model of CARMIL2 function in cells. CARMIL2 interacts 
with dynamic vimentin filaments at the leading edge of cells through 
its LRR domain. Interaction with vimentin is necessary for targeting 
CARMIL2 and its domains, such as the CBR and basic and 
hydrophobic membrane-binding domain, to functional membrane-
associated locations for lamellipodia formation, cell migration, and 
invadopodia formation.
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including inhibi tion and uncapping of by CARMIL, were performed 
as described (Wear et al., 2003; Kim et al., 2012). The actin concen-
tration was 1.5 μM, with 7% pyrene label. For capping assays, 10 nM 
CP was added to a mixture of pyrene-labeled actin and spectrin–ac-
tin seeds at time zero. To assay for reversal of capping, pyrene–actin 
was polymerized from seeds in the presence of 10 nM CP. After 
200 s, the CBR fragment of CARMIL was added, and polymerization 
was followed for 300 s. Apparent binding-affinity constants between 
CP and CBR were determined by fitting the data to polymerization 
rate equations with Berkeley Madonna (www.berkeleymadonna.
com), based on the following mechanism:
Reaction 1 A + N AN
Reaction 2 AN + CP CPN




















In these reactions, A is actin monomer, Nb is free barbed end, CP 
is capping protein, CPNb is capped barbed end, and CBR is CBR-
CARMIL. These equations assume that a capped barbed end, 
CPNb, can neither add nor lose actin subunits and that the complex 
of CP with CARMIL, CPCBR, cannot interact with a barbed end. For 
the elongation rate constants in Reaction 1, k+ was 11.6 μM−1s−1 and 
k- was 1.4 s−1 (Pollard, 1986). The rate constants for capping in Reac-
tion 2 were determined by fitting the experimental data for seeded 
actin polymerization with a series of concentrations of CP. The rate 
constants for CP binding to CARMIL in Reaction 3 were determined 
by fitting a set of experimental data produced by addition of CAR-
MIL at various concentrations to 10 nM CP.
Cell migration in a wound-healing model
HT1080 cells were infected with lentivirus for endogenous CARMIL2 
depletion and expression rescue of mutants and chimeras. Infected 
cells were grown to a confluent monolayer on glass-bottom cell cul-
ture dishes (MatTek) coated with 30 μg/ml fibronectin (Sigma-
Aldrich). At 72 h postinfection, a wound was scratched with a pipette 
tip. Measurements were made every hour for 4 h using an ocular 
micrometer.
Invadopodia matrix-degradation assay
Coverslips coated with fluorescent gelatin (Life Technologies) were 
prepared as previously described (Artym et al., 2009). HT1080 cells 
were infected with lentivirus for depletion of CARMIL2 and expres-
sion rescue as above. At 72 h postinfection, cells were plated onto 
fluorescent gelatin–coated coverslips. Cells were allowed to de-
grade the matrix for 3 h before fixation, permeabilization, and phal-
loidin staining.
To quantitate matrix degradation, we created a binary image 
from the fluorescent gelatin image by imposing a threshold at three 
SDs below the mean pixel intensity. Total cell area and area of deg-
radation were measured from phalloidin-stained images and binary 
images, respectively, using ImageJ. To avoid counting stray pixels in 
the area of degradation, we constrained the analysis to areas greater 
than 10 pixels.
Statistical analysis
We performed Student’s t test on population values to determine 
whether means differed by statistically significant amounts. Data 
analysis and graphical representations were done using Prism 6 
(GraphPad, La  Jolla, CA).
For live-cell fluorescence movies, cells were grown on glass-bot-
tom culture dishes (MatTek, Ashland, MA) coated with 30 μg/ml fi-
bronectin (Sigma-Aldrich). Cells were maintained at 37°C with 5.0% 
CO2. Spinning-disk confocal or wide-field fluorescence images were 
captured every 6 s for up to 10 min using a 100×/1.4 NA objective. 
Cells were imaged 24 h posttransfection. Heat-map pseudocoloring 
was performed in ImageJ using the Fire look-up table.
For phase-contrast movies, cells were handled in a similar man-
ner. Images of migrating single cells (n = 30) were acquired every 
60 s for 1 h using a 60×/1.4 NA phase-contrast objective on an 
Olympus IX70 inverted microscope. Cells were imaged 72 h postin-
fection with lentivirus. To avoid observer bias in selecting cells for 
movie analysis, we imaged the first 30 isolated cells encountered 
when systemically surveying the disk in a grid pattern.
To quantitate polarity, we calculated circularity as (areacell × 4π)/
(perimetercell2) (Thurston et al., 1988). ImageJ was used to measure 
the area and perimeter of single cells from initial frames of time-
lapse movies (n = 30). Macropinosomes were counted as phase-
bright vesicles in the initial frame of phase-contrast time-lapse 
movies (n = 30) of single cells. For calculating mean-squared dis-
placement, distance traveled, and persistence, displacements of 
individual cell nuclei were tracked frame by frame. For quantitation 
of colocalization, Manders overlap coefficients were calculated us-
ing ImageJ from images of cells coexpressing GFP-CARMIL2 con-
structs and vimentin-tdTomato. Kymographs along vimentin fila-
ments were generated using ImageJ with a 5-pixel line width.
Coimmunoprecipitations and immunoblots
Immunoprecipitation with anti-FLAG M2 affinity beads (Sigma-Al-
drich) was performed according to the manufacturer’s instructions. 
The beads were washed, and precipitated protein was eluted with 
3X-FLAG peptide. Supernatant was boiled with SDS-loading buffer 
and analyzed by SDS–PAGE and immunoblotting.
Immunoblots were performed with the primary and secondary 
antibodies listed above. Immunoblots were developed with Super-
Signal West Pico Chemiluminescent substrate (Thermo-Scientific) 
and exposed to autoradiography film.
Protein expression and purification
The CBR fragments of human CARMIL2b Pro-961–Arg-1072 (pBJ 
1843) were amplified from cDNA by PCR and cloned into pGEX-
6P-3 (GE Healthcare, Piscataway, NJ). Complete DNA sequencing 
of the in sert and junctions verified the identity and integrity of the 
plasmids. The mutant CARMIL2-CBR RR985/987AA was created us-
ing QuikChange site-directed mutagenesis (Stratagene). GST-fusion 
proteins were expressed in BL21 (DE3) Escherichia coli and purified 
with glutathione Fast-Flow Sepharose resin (GE Healthcare). Cul-
tures were grown and induced with isopropyl-β-d-thiogalactoside at 
23°C. After elution from the gluta thione resin, GST-CBR was mixed 
with PreScission protease (GE Healthcare). The mixture was dialyzed 
into S-Sepharose buffer A (10 mM Tris, pH 8.0, 10 mM KCl, 0.1 mM 
EDTA, 0.5 mM dithiothre itol [DTT], 1 mM NaN3) overnight, applied 
to an S-Sepharose col umn, and eluted with a KCl gradient (10–700 
mM). For storage, CBR was dialyzed into 10 mM Tris (pH 8.0), 40 
mM KCl, 0.1 mM EDTA, 0.5 mM DTT, and 1 mM NaN3 and kept on 
wet ice. The concentra tion of CBR was calculated from A280, based 
on predicted extinction coefficients, and confirmed by SDS–PAGE 
with Coomassie blue staining.
Actin polymerization assays
Actin was purified from rabbit skeletal muscle as previously 
described (Wear et al., 2003). Pyrene–actin polymerization assays, 
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